Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học General Psychiatry cung cấp cho các bạn kiến thức về ngành y đề tài: The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases. | Available online http content 9 5 R103 Research article The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases Chenglong Han1 Josef S Smolen2 Arthur Kavanaugh3 Désirée van der Heijde4 Jurgen Braun5 René Westhovens6 Ning Zhao1 Mahboob U Rahman1 Daniel Baker1 and Mohan Bala1 1Centocor Research and Development Inc. 200 Great Valley Parkway Malvern Pennsylvania 1 9355 USA 2Division of Rheumatology Internal Medicine III Medical University of Vienna and Hietzing Hospital Waehringer Guertel 18-20 A-1090 Vienna Austria 3Division of Rheumatology Allergy and Immunology University of California San Diego 9500 Gilman Drive LaJolla California 92093 USA 4Department of Rheumatology Leiden University Medical Center PO Box 9600 2300 RC Leiden The Netherlands 5Rheumazentrum Ruhrgebiet Landgrafenstrasse 15 D-44652 Herne Germany 6Division of Rheumatology UZ Gasthuisberg Herestraat 49 3000 Leuven Belgium Corresponding author Chenglong Han chan3@ Received 30 Mar 2007 Revisions requested 25 May 2007 Revisions received 16 Aug 2007 Accepted 8 Oct 2007 Published 8 Oct 2007 Arthritis Research Therapy 2007 9 R103 doi ar2306 This article is online at http content 9 5 R103 2007 Chenglong Han et al. licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Open Access Abstract In this study we compare the health-related quality of life HRQoL of patients with moderate-to-severe rheumatoid arthritis RA psoriatic arthritis PsA and ankylosing spondylitis AS and study the effect of treatment with infliximab on the HRQoL of patients with these diseases. Short Form Health Survey-36 SF-36 data from the placebo-controlled phases of 4 studies of infliximab in .
